Ovid Therapeutics Inc.
US ˙ NasdaqCM ˙ US6904691010

SecurityOVID / Ovid Therapeutics Inc.
InstitutionState Street Corp
Latest Disclosed Ownership520,283 shares
Latest Disclosed Value $ 1,155,028
State Street Corp reports 88.14% increase in ownership of OVID / Ovid Therapeutics Inc.

On May 15, 2026 - State Street Corp filed a 13F-HR form disclosing ownership of 520,283 shares of Ovid Therapeutics Inc. (US:OVID) valued at $1,155,028 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 276,533 shares of Ovid Therapeutics Inc.. This represents a change in shares of 88.14% during the quarter. The current value of the position is $1,290,302 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OVID THERAPEUTICS COM 690469101 520,283 243,750 88.14 1,155 156.67 0.0000
2026-02-13 2025-12-31 13F OVID THERAPEUTICS COM 690469101 276,533 49,500 21.80 451 52.54 0.0000
2025-11-14 2025-09-30 13F OVID THERAPEUTICS COM 690469101 227,033 0 0.00 295 298.65 0.0000
2025-08-14 2025-06-30 13F OVID THERAPEUTICS COM 690469101 227,033 -1,145,075 -83.45 75 -82.67 0.0000
2025-05-15 2025-03-31 13F OVID THERAPEUTICS COM 690469101 1,372,108 -22,410 -1.61 428 -67.20 0.0000
2025-02-14 2024-12-31 13F OVID THERAPEUTICS COM 690469101 1,394,518 33,063 2.43 1,302 -18.93 0.0001
2024-11-14 2024-09-30 13F OVID THERAPEUTICS COM 690469101 1,361,455 7,084 0.52 1,607 54.27 0.0001
2024-08-14 2024-06-30 13F OVID THERAPEUTICS COM 690469101 1,354,371 198,724 17.20 1,042 -70.46 0.0000
2024-05-15 2024-03-31 13F OVID THERAPEUTICS COM 690469101 1,155,647 35,300 3.15 3,525 -2.30 0.0002
2024-02-14 2023-12-31 13F OVID THERAPEUTICS COM 690469101 1,120,347 11,288 1.02 3,608 -15.29 0.0002
2023-11-14 2023-09-30 13F OVID THERAPEUTICS COM 690469101 1,109,059 82,428 8.03 4,259 26.46 0.0002
2023-08-14 2023-06-30 13F OVID THERAPEUTICS COM 690469101 1,026,631 834,898 435.45 3,367 581.58 0.0002
2023-05-15 2023-03-31 13F OVID THERAPEUTICS COM 690469101 191,733 0 0.00 495 38.76 0.0000
2023-05-15 2022-12-31 13F/A-99 OVID THERAPEUTICS COM 690469101 191,733 0 0.00 357 0.85 0.0000
2023-05-15 2022-12-31 13F OVID THERAPEUTICS COM 690469101 191,733 0 357 0.0000
2022-11-15 2022-09-30 13F OVID THERAPEUTICS COM 690469101 191,733 0 0.00 353 -14.32 0.0000
2022-08-15 2022-06-30 13F OVID THERAPEUTICS COM 690469101 191,733 0 0.00 412 -31.56 0.0000
2022-05-16 2022-03-31 13F OVID THERAPEUTICS COM 690469101 191,733 46,884 32.37 602 29.46 0.0000
2022-02-14 2021-12-31 13F OVID THERAPEUTICS COM 690469101 144,849 0 0.00 465 -4.52 0.0000
2021-11-15 2021-09-30 13F OVID THERAPEUTICS COM 690469101 144,849 -12,000 -7.65 487 -20.55 0.0000
2021-08-16 2021-06-30 13F OVID THERAPEUTICS COM 690469101 156,849 -1,047,516 -86.98 613 -87.34 0.0000
2021-07-09 2021-03-31 13F/A-1 OVID THERAPEUTICS COM 690469101 1,204,365 464,925 62.88 4,842 183.49 0.0003
2021-05-17 2021-03-31 13F OVID THERAPEUTICS COM 690469101 1,204,365 464,925 4,842 0.0003
2021-02-16 2020-12-31 13F OVID THERAPEUTICS COM 690469101 739,440 12,208 1.68 1,708 -59.08 0.0001
2020-11-10 2020-09-30 13F OVID THERAPEUTICS COM 690469101 727,232 -8,724 -1.19 4,174 -23.05 0.0003
2020-08-14 2020-06-30 13F OVID THERAPEUTICS COM 690469101 735,956 735,956 5,424 0.0004
2019-08-14 2019-06-30 13F OVID THERAPEUTICS COM 690469101 0 -187,915 -100.00 0 -100.00
2019-05-15 2019-03-31 13F OVID THERAPEUTICS COM 690469101 187,915 18,100 10.66 333 -18.98 0.0000
2019-02-12 2018-12-31 13F OVID THERAPEUTICS COM 690469101 169,815 -13,949 -7.59 411 -60.52 0.0000
2018-11-09 2018-09-30 13F OVID THRPUTCS Common equity shares 690469101 183,764 43,020 30.57 1,041 -5.19 0.0001
2018-08-14 2018-06-30 13F OVID THRPUTCS Common equity shares 690469101 140,744 35,016 33.12 1,098 46.99 0.0001
2018-05-15 2018-03-31 13F OVID THRPUTCS Common equity shares 690469101 105,728 30,162 39.91 747 -0.13 0.0001
2018-02-14 2017-12-31 13F OVID THRPUTCS Common equity shares 690469101 75,566 3,631 5.05 748 21.43 0.0001
2017-11-14 2017-09-30 13F OVID THRPUTCS Common equity shares 690469101 71,935 22,335 45.03 616 18.46 0.0001
2017-08-14 2017-06-30 13F OVID THRPUTCS Common equity shares 690469101 49,600 49,600 520 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.